The Oncology Institute, Inc.

NASDAQ:TOI

0.47 (USD) • At close July 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Revenue 324.239252.483203.003187.515155.405113.16
Cost of Revenue 270.539200.39162.155150.636125.46586.879
Gross Profit 53.752.09340.84836.87929.94126.282
Gross Profit Ratio 0.1660.2060.2010.1970.1930.232
Reseach & Development Expenses 000000
General & Administrative Expenses 0000.30900
Selling & Marketing Expenses 00041.58800
SG&A 113.737119.68983.36541.89729.64420.389
Other Expenses -0.7044.4113.3413.1782.9421.103
Operating Expenses 113.737124.186.70645.07532.58521.492
Operating Income -60.037-72.007-45.858-8.196-2.6354.79
Operating Income Ratio -0.185-0.285-0.226-0.044-0.0170.042
Total Other Income Expenses Net -23.06773.91134.26-6.618-0.0030.071
Income Before Tax -83.1041.904-11.598-14.814-2.6384.861
Income Before Tax Ratio -0.2560.008-0.057-0.079-0.0170.043
Income Tax Expense -0.0360.247-0.671-0.4931.3830.913
Net Income -67.8771.657-10.927-14.321-4.0213.948
Net Income Ratio -0.2090.007-0.054-0.076-0.0260.035
EPS -0.920.023-0.16-0.24-0.0620.14
EPS Diluted -0.920.021-0.16-0.24-0.0620.14
EBITDA -54.164-67.096-41.471-11.2890.3075.965
EBITDA Ratio -0.167-0.266-0.204-0.060.0020.053